Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have cystic fibrosis, confirmed by a sweat test result above 60 mmol/l
- People who carry at least one copy of the DeltaF508 gene mutation associated with cystic fibrosis
- People whose ongoing care is provided by a cystic fibrosis centre that is part of this study
- People for whom a treating doctor is starting the combination treatment elexacaftor/tezacaftor/ivacaftor as part of their regular care, in line with the approved uses of this medication at the time of joining
- People who fall within the age range specified by the current approved guidelines for this medication
- People who are covered by the French social security system
- People (or, for children, their parents or legal guardians) who have given their consent to take part before any study-related assessments are carried out
- People who agree to be included in follow-up studies for patients treated with elexacaftor/tezacaftor/ivacaftor, as part of the French cystic fibrosis patient registry
Who may not be able to join:
- People who are starting elexacaftor/tezacaftor/ivacaftor as part of another clinical trial, rather than as part of their routine care
- People who are already taking a CFTR modulator medication, including the combination lumacaftor/ivacaftor
- People who are pregnant, or who are under legal guardianship or curatorship
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Raphaël Enaud, MDPhD, University Hospital, Bordeaux
Phone: 0557820877
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
composition of the digestive bacterial microbiota
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.